Company: INGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029993
Chunk: 65

Company: Inogen Inc
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1B
Chunk 65
---
 ended December 31,

    Non-GAAP EBITDA and Adjusted EBITDA
     
    2024

    2023

    2022

    Net loss (GAAP)
     
    $
    (35,888
    )
     
    $
    (102,449
    )
     
    $
    (83,772
    )

    Non-GAAP adjustments:

    Interest income, net

    (5,190
    )

    (6,574
    )

    (2,837
    )

    Provision (benefit) for income taxes

    (588
    )

    105

    504

    Depreciation and amortization

    21,004

    18,152

    23,514

    EBITDA (non-GAAP)

    (20,662
    )

    (90,766
    )

    (62,591
    )

    Stock-based compensation

    7,397

    7,427

    12,283

    Acquisition-related expenses

    784

    2,413

    —

    Restructuring-related and other charges

    —

    3,426

    —

    Impairment charges

    —

    32,894

    —

    Change in fair value of earnout liability

    3,000

    6,822

    (15,386
    )

    Loss on disposal of intangible asset

    —

    —

    52,161

    Adjusted EBITDA (non-GAAP)
     
    $
    (9,481
    )
     
    $
    (37,784
    )
     
    $
    (13,533
    )

 73

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 

We are exposed to various market risks, including fluctuation in foreign currency exchange rates and interest rates. Market risk is the potential loss arising from adverse changes in market rates and prices. We do not hold or issue financial instruments for trading purposes.

Foreign currency exchange risk 

The principal market risk we face is foreign currency exchange risk. The majority of our revenue is denominated in U.S. dollars while the majority of our European sales are denominated in Euros. Our results of operations, certain balance sheet balances and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange